3880.HK · MEDTIDE
Hong Kong · RS rating 55 · As of 2026-10-14
| Price | 21.32 HKD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 55 / 89 / 37 / 39 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 20 / 8 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +34.9% |
| Market cap (USD) | $375.1M |